Astrarta Aeterna | Official

LIMITS ARE
FOR THEM.

Astrarta Aeterna develops antidepressants and analgesics for people who cannot let biology set the ceiling. Our compounds restore energy, clear the fog and take pain out of the decision loop, so ambition stays limited only by your choice.

"People spent a long time trying to beat me into being normal and knowing my place.
I had nothing at the start, stopped asking for permission, and took what was mine by right. I built this company to hand you the same power.
Pain and fear are how the world keeps the average man small, but you are not him.
The world is full of limits,
but limits are for them."

The legacy of Astrarta Aeterna is built on the refusal to accept biological limitations. Martin McAlovitz envisioned a system where result is the only measure of success. We restore the human capacity to dominate reality.

Martin McAlovitz

AETEREX

Advanced neuro-corrector engineered for high-performance environments. Aeterex targets apathy and chronic fatigue at the neural level. It restores vivid clarity and absolute drive for global productivity.

VELARIS

Analgesic technology that overrides the brain's priority for pain. Velaris ensures discomfort is an irrelevant variable. Absolute physical dominance over sensory interference.

SITRI-PRIME

Pinnacle of neuro-efficiency. Sitri-PRIME is a restricted formula for clinical settings. It provides the highest permissible cognitive leverage for those defining the global landscape.

Dravest Headquarters

The central command center for global strategy and corporate affairs in Avarost. A hub for cross-continental operational management.

Automated Manufacturing

State-of-the-art facility for pharmaceutical штамповка, precision packaging, and autonomous quality control protocols.

Logistics Hub

Secured distribution terminal providing rapid product transit to 40 international markets via proprietary logistics channels.

Clinical Network

Exclusive medical стационар network providing specialized therapy and high-end recovery services for institutional partners.